Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nuclear survivin expression in small cell lung cancer.
Yano Y, Otsuka T, Hirano H, Uenami T, Satomi A, Kuroyama M, Niinaka M, Yoneda T, Kimura H, Mori M, Yamaguchi T, Yokota S. Yano Y, et al. Among authors: yamaguchi t. Anticancer Res. 2015 May;35(5):2935-9. Anticancer Res. 2015. PMID: 25964579
Case series of pleomorphic carcinomas of the lung treated with nivolumab.
Kanazu M, Uenami T, Yano Y, Nakatsubo S, Hosono Y, Ishijima M, Akazawa Y, Yamaguchi T, Urasaki K, Mori M, Yokota S. Kanazu M, et al. Among authors: yamaguchi t. Thorac Cancer. 2017 Nov;8(6):724-728. doi: 10.1111/1759-7714.12505. Epub 2017 Sep 7. Thorac Cancer. 2017. PMID: 28881488 Free PMC article.
Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient.
Hosono Y, Sawa N, Nakatsubo S, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yano Y, Mori M, Yamaguchi T, Yokota S. Hosono Y, et al. Among authors: yamaguchi t. Intern Med. 2018 May 1;57(9):1281-1285. doi: 10.2169/internalmedicine.9338-17. Epub 2017 Dec 27. Intern Med. 2018. PMID: 29279483 Free PMC article.
Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Yamamoto Y, Yano Y, Kuge T, Okabe F, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yamaguchi T, Mori M. Yamamoto Y, et al. Among authors: yamaguchi t. Thorac Cancer. 2020 Nov;11(11):3317-3325. doi: 10.1111/1759-7714.13675. Epub 2020 Sep 28. Thorac Cancer. 2020. PMID: 32986306 Free PMC article.
Non-small cell lung cancer with tumor proportion score > 90% could increase the risk of severe immune-related adverse events in first-line treatments with immune checkpoint inhibitors: A retrospective single-center study.
Akazawa Y, Yoshikawa A, Kanazu M, Yano Y, Yamaguchi T, Mori M. Akazawa Y, et al. Among authors: yamaguchi t. Thorac Cancer. 2022 Sep;13(17):2450-2458. doi: 10.1111/1759-7714.14576. Epub 2022 Jul 12. Thorac Cancer. 2022. PMID: 35820673 Free PMC article.
9,344 results